Revolution Medicines Inc (RVMD)
38.33
+0.16
(+0.42%)
USD |
NASDAQ |
May 31, 16:00
38.33
0.00 (0.00%)
After-Hours: 20:00
Revolution Medicines Cash from Operations (Quarterly): -160.56M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -160.56M |
| December 31, 2023 | -120.56M |
| September 30, 2023 | -100.50M |
| June 30, 2023 | -67.12M |
| March 31, 2023 | -62.39M |
| December 31, 2022 | -61.79M |
| September 30, 2022 | -51.74M |
| June 30, 2022 | -55.72M |
| March 31, 2022 | -55.16M |
| December 31, 2021 | -39.26M |
| September 30, 2021 | -36.59M |
| Date | Value |
|---|---|
| June 30, 2021 | -34.08M |
| March 31, 2021 | -37.25M |
| December 31, 2020 | -25.03M |
| September 30, 2020 | -27.02M |
| June 30, 2020 | -19.99M |
| March 31, 2020 | -28.02M |
| December 31, 2019 | -11.65M |
| September 30, 2019 | -13.86M |
| June 30, 2019 | -11.50M |
| March 31, 2019 | -12.60M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-160.56M
Minimum
Mar 2024
-11.50M
Maximum
Jun 2019
-50.99M
Average
-38.26M
Median
Cash from Operations (Quarterly) Benchmarks
| Day One Biopharmaceuticals Inc | -49.73M |
| Iovance Biotherapeutics Inc | -122.28M |
| TRACON Pharmaceuticals Inc | -2.543M |
| Beam Therapeutics Inc | -99.75M |
| Zentalis Pharmaceuticals Inc | -51.97M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -247.97M |
| Cash from Financing (Quarterly) | 0.81M |
| Free Cash Flow | -457.88M |
| Free Cash Flow Per Share (Quarterly) | -0.9939 |
| Free Cash Flow Yield | -9.15% |